Publications in collaboration with researchers from Universitat de Barcelona (149)

2024

  1. Clinical features and prognosis of prosthetic valve endocarditis due to Staphylococcus aureus

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 10, pp. 1989-2000

  2. Costs and resource utilization patterns in surgical site infections: a pre-COVID-19 perspective from France, Germany, Spain, and the UK

    Journal of Hospital Infection, Vol. 147, pp. 123-132

  3. Epidemiology and Risk Factors of Mycotic Aneurysm in Patients With Infective Endocarditis and the Impact of its Rupture in Outcomes. Analysis of a National Prospective Cohort

    Open Forum Infectious Diseases, Vol. 11, Núm. 3

  4. Evolution of invasive pneumococcal disease by serotype 3 in adults: a Spanish three-decade retrospective study

    The Lancet Regional Health - Europe, Vol. 41

  5. Individual and institutional predisposing factors of MRSA surgical site infection and outcomes-a retrospective case-control-study in 14 European high-volume surgical centres

    JAC-Antimicrobial Resistance, Vol. 6, Núm. 2

  6. Infective endocarditis in HIV-infected patients. Analysis of a national cohort

    Infectious Diseases

  7. Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM

    Intensive Care Medicine, Vol. 50, Núm. 4, pp. 502-515

  8. Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update

    Transplantation Reviews, Vol. 38, Núm. 4

  9. Prevalence and prognostic impact of stroke in a national cohort of infective endocarditis

    International Journal of Stroke

2023

  1. A New Integrative and Mobilizable Element Is a Major Contributor to Tetracycline Resistance in Streptococcus dysgalactiae subsp. equisimilis

    Antibiotics, Vol. 12, Núm. 3

  2. Clinical presentation, microbiology, and prognostic factors of prosthetic valve endocarditis. Lessons learned from a large prospective registry

    PloS one, Vol. 18, Núm. 9, pp. e0290998

  3. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

    International Journal of Infectious Diseases, Vol. 137, pp. 134-143

  4. Correction: Epidemiological Changes and Improvement in Outcomes of Infective Endocarditis in Europe in the Twenty-First Century: An International Collaboration on Endocarditis (ICE) Prospective Cohort Study (2000–2012) (Infectious Diseases and Therapy, (2023), 12, 4, (1083-1101), 10.1007/s40121-023-00763-8)

    Infectious Diseases and Therapy

  5. Cost analysis of disease including treatment with dalbavancin in a Spanish hospital: ECODAL ANALYSIS

    Journal of medical economics, Vol. 26, Núm. 1, pp. 463-472

  6. Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae

    American Journal of Transplantation, Vol. 23, Núm. 7, pp. 1022-1034

  7. Epidemiological Changes and Improvement in Outcomes of Infective Endocarditis in Europe in the Twenty-First Century: An International Collaboration on Endocarditis (ICE) Prospective Cohort Study (2000–2012)

    Infectious Diseases and Therapy, Vol. 12, Núm. 4, pp. 1083-1101

  8. Executive summary of the consensus statement of the group for the study of infection in transplantation and other immunocompromised host (GESITRA-IC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the treatment of SARS-CoV-2 infection in solid organ transplant recipients

    Transplantation Reviews

  9. Heart transplantation as salvage treatment of intractable infective endocarditis

    Infectious Diseases, Vol. 55, Núm. 5, pp. 370-374

  10. Identification of Mycobacterium abscessus Subspecies by MALDI-TOF Mass Spectrometry and Machine Learning

    Journal of clinical microbiology, Vol. 61, Núm. 1, pp. e0111022

  11. Impact of Intermediate Susceptibility to Penicillin on Antimicrobial Treatment and Outcomes of Endocarditis Caused by Viridans and Gallolyticus Group Streptococci

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 77, Núm. 9, pp. 1273-1281